Skip to main content

Table 2 Prognostic factors for the time to re-bleeding

From: Role of palliative radiotherapy in bleeding control in patients with unresectable advanced gastric cancer

Variables Univariate analysis Multivariate analysis
Hazard ratio (95% CI) p value Hazard ratio (95% CI) p value
Age 0.977 (0.948–1.007) 0.129   
ECOG performance status (< 2) 1.599 (0.669–3.820) 0.291   
Hematemesis (no) 1.544 (0.679–3.509) 0.300   
Hemostasis interventions before radiotherapy (no) 1.542 (0.678–3.504) 0.301   
Baseline hemoglobin level 1.052 (0.824–1.342) 0.684   
Amount of transfusion before radiotherapy 1.020 (0.973–1.070) 0.409   
Biologically effective dose 0.919 (0.875–0.966) 0.001 0.871 (0.788–0.963) 0.007
Additional chemotherapy after radiotherapy (no) 0.303 (0.132–0.697) 0.005 0.276 (0.114–0.670) 0.004
  1. CI Confidence interval; ECOG Eastern Cooperative Oncology Group
  2. Values in parentheses were set as the reference.